Statute Details
- Title: Medicines (Cessation of Application of Act to Medical Devices) Order 2010
- Act Code: MA1975-S439-2010
- Legislation Type: Subsidiary Legislation (SL)
- Authorising Act: Medicines Act (Cap. 176), section 77
- Legislation Number: S 439/2010
- Date of Making: 5 August 2010
- Commencement: 10 August 2010
- Status: Current version as at 27 March 2026
- Key Provisions: Sections 1–3 (citation/commencement; definition; cessation of application)
What Is This Legislation About?
The Medicines (Cessation of Application of Act to Medical Devices) Order 2010 is a short but legally significant instrument. In essence, it marks a regulatory boundary shift: it stops the Medicines Act from applying to medical devices as from 10 August 2010.
Before this Order took effect, medical devices were treated—at least in part—under the medicines regulatory framework. The Order reflects a policy and legislative consolidation under Singapore’s health product regulatory regime, where medical devices are instead governed under the Health Products Act (Cap. 122D). The Order therefore functions as a “switch-off” mechanism for the Medicines Act’s application to devices.
For practitioners, the practical importance lies in compliance and classification. If a product is a “medical device” under the relevant definition, the regulatory obligations, licensing pathways, and enforcement provisions are no longer those under the Medicines Act. Instead, the governing framework becomes the Health Products Act and its subsidiary legislation.
What Are the Key Provisions?
Section 1 (Citation and commencement) provides the formal identity of the instrument and its effective date. The Order may be cited as the Medicines (Cessation of Application of Act to Medical Devices) Order 2010 and “shall come into operation on 10th August 2010.” This is crucial for determining the regulatory regime applicable to conduct and approvals around that date—e.g., whether applications, authorisations, or enforcement actions fall under the Medicines Act or the Health Products Act.
Section 2 (Definition) defines “medical device” by reference to another statute. Specifically, it means a medical device “referred to in the First Schedule to the Health Products Act (Cap. 122D).” This cross-reference technique is common in Singapore legislation and has two legal consequences. First, it anchors the meaning of “medical device” to the Health Products Act’s scheduled categories. Second, it reduces interpretive uncertainty: rather than litigating what constitutes a medical device for Medicines Act purposes, the definition points directly to the Health Products Act schedule.
Section 3 (Cessation of application of Act) is the operative provision. It states that “the provisions of the Act shall cease to apply to any medical device as from 10th August 2010.” The “Act” in context is the Medicines Act. In plain language, from the commencement date, the Medicines Act’s regulatory provisions no longer govern medical devices.
Although the Order contains only three sections, its legal effect is broad. “Cease to apply” means that the Medicines Act’s requirements—whatever they are in the Medicines Act—are no longer the controlling legal obligations for medical devices. This includes, in practical terms, the compliance regime that would otherwise be triggered by the Medicines Act (such as licensing/registration requirements, restrictions on supply, and enforcement powers that attach to medicines). The Order does not itself restate the alternative regime; instead, it clears the way for the Health Products Act framework to govern medical devices.
How Is This Legislation Structured?
The Order is structured as a compact subsidiary instrument with an enacting formula and three numbered provisions:
(1) Section 1: Citation and commencement. This section establishes when the Order takes effect.
(2) Section 2: Definition. This section defines “medical device” by reference to the First Schedule to the Health Products Act.
(3) Section 3: Cessation of application of Act. This is the operative clause that stops the Medicines Act from applying to medical devices from the commencement date.
There are no schedules, no detailed transitional provisions, and no procedural steps within this Order itself. Its role is therefore primarily “regime reallocation”—a legal mechanism to ensure that the correct statutory framework applies to the correct category of regulated products.
Who Does This Legislation Apply To?
This Order applies to “any medical device” as defined in section 2. In practice, that means it affects all persons and entities whose regulatory obligations depend on whether a product is treated as a medicine or as a medical device. These include manufacturers, importers, distributors, wholesalers, retailers, and healthcare-related suppliers who place medical devices on the market.
Because the definition of “medical device” is tied to the First Schedule to the Health Products Act, the scope is determined by the scheduled categories in that Act. Lawyers advising product regulatory strategy must therefore assess the product’s classification against the Health Products Act schedule to determine whether the Medicines Act is excluded by this Order.
Why Is This Legislation Important?
Despite its brevity, the Order is important because it changes the legal compliance landscape. In Singapore’s health product regulation, the Medicines Act and the Health Products Act are not interchangeable. They can involve different regulatory pathways, different licensing/approval requirements, and different enforcement structures. By ceasing the Medicines Act’s application to medical devices, the Order ensures that medical devices are regulated under the intended statutory framework.
For practitioners, the key significance is classification and regulatory mapping. If a product is a medical device, counsel must ensure that the client’s regulatory submissions, quality management expectations, labelling and claims compliance, and market authorisation strategy are aligned with the Health Products Act regime rather than the Medicines Act regime. Conversely, if a product is not within the definition (i.e., not within the First Schedule categories), the Medicines Act may still be relevant.
The Order also has temporal implications. The commencement date—10 August 2010—can matter for historical compliance reviews, due diligence, and regulatory audits. For example, in a transaction or dispute involving past conduct, it may be necessary to determine which statutory regime applied at the time. The Order provides a clear date for the transition: from that date, the Medicines Act provisions cease to apply to medical devices.
Related Legislation
- Medicines Act (Cap. 176) — authorising Act (section 77) and the Act whose application is ceased to medical devices
- Health Products Act (Cap. 122D) — the governing framework for medical devices, including the First Schedule referenced in the definition
- Medicines (Cessation of Application of Act to Medical Devices) Order 2010 (S 439/2010) — the instrument analysed
Source Documents
This article provides an overview of the Medicines (Cessation of Application of Act to Medical Devices) Order 2010 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.